animal health

Lilly’s Elanco Expects IPO to Raise $1.4B
IPOs

Lilly’s Elanco Expects IPO to Raise $1.4B

The animal health spinoff is the second major industry player to go public, following Zoetis' successful offering.
By Matthew Heller | September 6, 2018
Read More
Eli Lilly to Spin Off Animal-Health Business
Corporate Finance

Eli Lilly to Spin Off Animal-Health Business

Eli Lilly reported a quarterly loss of $260 million and announced plans for an IPO of Elanco by the end of 2018.
By William Sprouse | July 24, 2018
Read More
Lilly Buys Vetmedica Pet Vaccines for $885M
Strategy

Lilly Buys Vetmedica Pet Vaccines for $885M

The deal will diversify Lilly's Elanco animal medicine business, adding vaccines for rabies and other feline and canine illnesses.
By Matthew Heller | October 5, 2016
Read More
Zoetis Gives Back Post-Takeover Report Gains
Strategy

Zoetis Gives Back Post-Takeover Report Gains

Shares in the animal-health giant take a rollercoaster ride after a report of a possible acquisition by Valeant Pharmaceuticals.
By Matthew Heller | June 26, 2015
Read More